As part of our ongoing seminar series, the Centre of Research Excellence in Severe Asthma hosted Dr. Param Nair, for a webinar on Pathogenic Autoantibodies in Patients with Severe Eosinophilic Asthma on 29 November, 2017.
This presentation is not currently available, as data presented is currently under consideration for publication.
Dr. Nair is currently the Frederick E. Hargreave Teva Innovation Professor of Medicine in the Division of Respirology at McMaster University, Adjunct Professor of Medicine at McGill University, and Staff Respirologist at the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, where he looks after patients with complex obstructive airway diseases, severe asthma and eosinophilic lung disorders.
These unique multi-disciplinary clinics provide these patients access to biologics, molecular microbiology, novel pulmonary imaging, and bronchial thermoplasty, and opportunities to participate in research programs. His laboratory characterizes the types of bronchitis in airway diseases using biomarkers in sputum, identifies mechanisms of persistent bronchitis and airway hyperresponsiveness, and explores targeted therapies using small molecules and biologics.
Dr. Param Nair’s travel was supported by AstraZeneca